Gemein LAW, Gaubert S, Paquet C, Paillard J, Holst SC, Tveitstøl T, Haraldsen IRJH, Kam-Thong T, Hawellek DJ, Hipp JF, Engemann DA (2026)
Clinically altered brain activity may not look like aged brain activity: Implications for brain-age modeling and biomarker strategies
Alzheimers Dement (N Y), 12 (3), e70302
DOI 10.1002/trc2.70302, PubMed 42688976

Forsyth F, Diaz A, Andersson V, Haraldsen IH, Gove D (2026)
Ethical considerations of fluid biomarker use in alzheimer's disease - a rapid review
Aging Ment Health, 1-14 (in press)
DOI 10.1080/13607863.2026.2719938, PubMed 42669176

Perez A, Hammer HL, Andersson V, Saarinen T, Alfonsín S, Giuffrè GM, Caraglia N, Martellacci N, Ramírez-Toraño F, Tveitstøl T, Kinnunen A, Liljeström M, Hotta J, Koivisto AM, Quaranta D, Quijano-Rubio C, Kollmorgen G, Zetterberg H, Christensen E, Renvall H, Marra C, Maestú F, Rossini PM, Hatlestad-Hall C, Haraldsen IH (2026)
Cognitive components derived from traditional neuropsychological tests and their associations with plasma p-tau217 and p-tau181 in mild cognitive impairment: a multisite analysis
Geroscience (in press)
DOI 10.1007/s11357-026-02466-7, PubMed 42584831